Griseofulvin
Revision as of 16:19, 23 October 2016 by ClaireLewis (talk | contribs) (Created page with "==Administration== *Type: Antifungal *Dosage Forms: *Routes of Administration: Oral *Common Trade Names: ==Adult Dosing== *250-1000mg PO daily ==Pediatric Dosing== *1...")
Administration
- Type: Antifungal
- Dosage Forms:
- Routes of Administration: Oral
- Common Trade Names:
Adult Dosing
- 250-1000mg PO daily
Pediatric Dosing
- 13.6-22.7kg: 125-250mg PO daily
- >22.7kg: 250-500mg PO daily
Special Populations
- Pregnancy Rating: B
- Lactation risk: Infant risk cannot be ruled out
- Renal dosing:
- Hepatic dosing:
Contraindications
- Allergy to class/drug
- Hepatocellular failure
- Porphyria
- Pregnancy
Adverse Reactions
Serious
- Acroparesthesia
Common
- Photosensitivity, rash, urticaria
- Nausea/vomiting, diarrhea
- Headache
Pharmacology
- Half-life: 9-22h
- Metabolism: Liver
- Excretion:
Mechanism of Action
- Fungistatic, deposits into keratin precursor cells and inhibits fungal mitosis
